I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects…

I recently had the chance to deliver the keynote address at the 2022 MSL Society Conference in Las Vegas. It’s been a transformative year for pharma and life sciences, specifically…

The 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is…

Even now: two and a half years later, the COVID-19 pandemic continues to have a substantial impact on the activities of Medical Science Liaisons (MSLs), including access to Key…

When the FDA mandated guidelines earlier this year for broader clinical trial inclusion, it brought a long-standing challenge in pharma and life sciences into the spotlight. Here, Alexandra Moens, H1’s…

Pharma has long existed in elevated, prestigious academic institutions: ivory towers of reputable and revered centers of excellence famous for disseminating the latest in clinical research and medical breakthroughs.…

The Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the…

I remember it clearly. Me, Ian - our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values…

Because they serve as the bridge between research and commercial functions of life sciences companies, medical affairs can drive equity in clinical trials by proactively engaging with a diverse set…

In a recent issue of Nature that traced the origins of key opinion leaders in pharma back to a Pfizer launch in the mid-1950s, the article tracked the evolution and…